What is Kyverna Therapeutics, Inc.'s common stock?

Kyverna Therapeutics, Inc. (KYTX) reported common stock of $1K in Q1 2026.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Kyverna Therapeutics, Inc. KYTX Common Stock

Common Stock at other companies

Bristol-Myers SquibbBMY

$292M0.0%

Climb Bio, Inc.CLYM

$5K-28.6%

Artiva Biotherapeutics, Inc.ARTV

3K0.0%

Iovance Biotherapeutics, Inc.IOVA

$18K+28.6%

Viridian Therapeutics, Inc.VRDN

200M0.0%

Vor BiopharmaVOR

$19K+46.2%

Other financials

Income statement

See full

Operating income-$41.4M+12.7%

Net income-$39.7M+11.0%

EPS (diluted)-$0.66+35.9%

Balance sheet

See full

Cash & equivalents$32.2M-43.4%

Total debt$9.2M+32.1%

Total equity$195.6M-12.7%

Total assets$257.0M-1.4%

Cash flow

See full

Operating cash flow-$41.6M+7.4%

CapEx$2.0K-98.0%

Free cash flow-$33.5M+10.8%

Valuation

See full

Market cap$498.52M+276%

Enterprise value$475.49M+475%

Returns & leverage

See full

Return on equity-74.5%+74.4pp

Debt / equity0×0.0×

Current ratio8.1×+0.7×

Where this comes from

Reported directly by Kyverna Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kyverna Therapeutics, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kyverna Therapeutics, Inc.'s common stock?: Kyverna Therapeutics, Inc. (KYTX) reported common stock of $1K in Q1 2026.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).